The University of Queensland

A randomised placebo-controlled crossover trial of micronised resveratrol as a treatment for Friedreich ataxia (2019–2022)

Grant type:

Murdoch Childrens Research Institute

Researchers:

• 

  Associate Professor John O'Sullivan

  Principal Research Fellow
  

  UQ Centre for Clinical Research

  Faculty of Medicine

Funded by:

Murdoch Childrens Research Institute